NEW YORK — American Express Global Business Travel’s first-quarter 2026 print is the cleanest single-period look investors and corporate buyers have had at the post-CWT-close perimeter. Revenue of $840 million is up 35% year-on-year from $621 million in Q1 2025. Adjusted EBITDA landed at $150 million. Adjusted gross profit margin came in at 58%. The Q1 figure includes the impact of acquisitions, which the company flagged in its release.
Customer retention sits at 96% since September 2025 — the marker date is the CWT-close week — and includes CWT in the denominator. Total New Wins Value reached $3.4 billion in Q1 2026, with Pfizer flagged as the headline name in the wins column.
The simultaneous strategic disclosure is that Amex GBT has announced a proposed acquisition by Long Lake Management and is suspending future earnings conference calls and financial guidance. The Q1 release is therefore the last clean operating snapshot before the take-private process advances.
The CWT Close, In Frame
The CWT acquisition is the structural change shaping the rest of the year’s operating cadence. The deal was announced in March 2024 and closed September 2, 2025 — 17 months from announcement to close. The final consideration was approximately $540 million on a cash-free, debt-free basis, stepped down from the $570 million originally announced.
The path to close ran through the UK Competition and Markets Authority, which opened its investigation in June 2024 and cleared the deal in March 2025. The CMA review was the binding regulatory window; the US-side and EU-side reviews concluded ahead of the UK process.
At close, Amex GBT CEO Paul Abbott framed the integration commitment in customer-trust terms: “Today marks the start of an exciting relationship with CWT customers. We will listen, build trust and deliver the choice, value and service they expect.” The synergy target attached to the combine is approximately $155 million of annual run-rate identified synergies within three years.
For corporate procurement, the deal materially compresses the TMC competitive set at the global top end. The pre-deal market read had Amex GBT, BCD Travel and CWT as the three global TMCs at scale, with FCM Travel Solutions, CTM, and Reed & Mackay sitting one tier below. The post-close map has Amex GBT and BCD as the two scale players, with FCM, CTM, and Reed & Mackay holding their tier-two positions and competing harder for accounts that want a non-Amex-GBT global TMC for vendor-diversification reasons.
What Q1 Tells Us About The Integration
The 96% retention number is the load-bearing data point in Amex GBT’s narrative on the integration. The historical pattern in TMC consolidation is that meaningful book-of-business attrition shows up in the first one-to-four quarters post-close, as procurement teams use the integration window as a renegotiation lever or a vendor swap opportunity. A 96% number — if it holds through Q2 and Q3 — is the signal that the customer-side disruption from the CWT integration has been contained.
The Pfizer win is the other piece worth attention. Pharma-side corporate travel is one of the heavier-spend, more compliance-sensitive verticals in the TMC market, and a Pfizer win at Amex GBT’s stage of the integration is the kind of marquee logo that procurement-side buyers will be asked about in 2027 RFP-cycle reference calls.
The 58% adjusted gross profit margin is in the band Amex GBT has been guiding to since the SPAC-era investor materials. The company has historically argued that the TMC unit economics scale on incremental booking volume rather than on top-line revenue, and the Q1 margin print is consistent with that argument across the larger CWT-inclusive base.
The Long Lake Piece
The Long Lake Management proposed acquisition is the strategic overhang investors and large corporate customers are now pricing into the platform’s 12-to-24-month outlook. Amex GBT has suspended future earnings conference calls and financial guidance, which is the standard pre-close housekeeping move once a take-private process advances.
For corporate buyers, the practical question is whether the take-private changes anything about the platform roadmap — particularly the next-gen Egencia rebuild, the Concur Complete alliance, or the CWT integration cadence. The company has not publicly altered any of those workstreams’ timelines as part of the take-private disclosure, but the absence of forward earnings calls means the operational reporting cadence buyers have been using to track the integration will thin out through the close window.
The TMC competitive set behind Amex GBT — BCD Travel and FCM Travel Solutions in particular — has signaled that they expect the take-private window to produce a renewed wave of competitive cycles for accounts that want operating-cadence visibility from their TMC. That dynamic is the practical buyer-side effect of the Long Lake disclosure even before the deal is closed.
The Read For Corporate Procurement
For procurement and T&E leaders running 2027 RFP cycles, the post-Q1 picture produces three operating assumptions.
First, the global-scale TMC choice is now binary: Amex GBT or BCD. Programs that have been running Amex GBT and CWT as their two-vendor global setup need to revisit that structure because the second vendor is now inside the first.
Second, the FCM, CTM and Reed & Mackay tier is the credible non-binary alternative and is positioning aggressively for accounts that want vendor diversity. The competitive temperature in those tier-two RFPs has materially increased through the first half of 2026.
Third, the Long Lake take-private process introduces an operating-cadence risk that did not exist three months ago. Programs writing 2027 contracts with Amex GBT should be considering whether their service-level agreements and governance reviews carry the contractual specificity needed to survive an ownership transition.
The Q1 2026 print is, on its own, a strong operating quarter for Amex GBT. Layered against the CWT close, the Pfizer win, the Concur Complete alliance, and the Long Lake disclosure, it is also the data point that sets up the strategic conversation corporate buyers will be having with their TMCs through the rest of the year.